PharmaLeaders.com

News. Resources. Community.

Featured Article

Modernizing Therapeutic Cell Production

By

Article authored and contributed to PharmaLeaders by: Carlo Chatman, Power PR Cell and gene therapies are dominating the world of drug development. With the promise of significant breakthroughs in treatment of diabetes, cancer, and congenital conditions, it is no wonder that research and development is predicted to reach $232.5 billion by 2026, up from $186 […]

The Importance of Pharma Marketers Engaging with the Nation’s Leading Prescribers

By

Contributed to PharmaLeaders by: Richard Zwickel, Chairman and CEO POCN Group Each year in the United States, about 264,000 cases of breast cancer are diagnosed in women and about 2,400 cases are diagnosed in men. Nearly 42,500 people die from the disease annually. Nurse practitioners (NPs) and physician associates (PAs) take an active role in breast […]

More from this Category

White Papers

Pediatric Gene Therapy

The European approvals of Glybera® in 2012 and Strimvelis® in 2016 seem likely to be the vanguard of the therapeutic revolution heralded by the … FREE Download

Industry News

Daiichi Sankyo receives approval for ENHERTU in Japan

Daiichi Sankyo has received approval from Japan’s Ministry of Health, Labour and Welfare (MHLW) for ENHERTU (trastuzumab deruxtecan), a treatment for adult patients with HER2 low (IHC 1+ or IHC 2+/ISH-) unresectable or recurrent breast cancer after prior chemotherapy. ENHERTU, … [Read More...]

Macomics signs collaboration deal with Ono Pharmaceutical

Macomics and Ono Pharmaceutical have entered into a global collaboration deal for the discovery and development of macrophage-targeting antibody therapy for cancer. Under the deal terms, Macomics will be responsible for identifying and characterising the antibody candidates … [Read More...]

More from this Category